Histoplasmosis in a child with JRA on low-dose methotrexate [1]

Rheumatology

Volumn 46, Issue 1, 2007, Pages 177-178

  Hunstad, D A ^a   French, A R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; HEMOGLOBIN; ITRACONAZOLE; METHENAMINE; METHOTREXATE; NAPROXEN; PREDNISONE;

ARTHRALGIA; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HISTOPLASMA; HISTOPLASMOSIS; HOSPITAL ADMISSION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; LETTER; LEUKOCYTE COUNT; LOW DRUG DOSE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MEDIASTINUM LYMPH NODE; MORNING STIFFNESS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SCHOOL CHILD; SILVER STAINING; SORE THROAT; SPLENOMEGALY; SYNOVITIS; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; URINALYSIS; WEIGHT REDUCTION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HISTOPLASMOSIS; HUMANS; METHOTREXATE; OPPORTUNISTIC INFECTIONS;

EID: 33845585434     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel375     Document Type: Letter

References (10)

1. Deepe GS. Histoplasma capsulatum. In: Mandell GL, Bennett JE, Dolin R, Eds. Principles and practice of infectious diseases, 5th edn. Philadelphia: Churchill Livingstone, 2000;1:2718-33.
2. Wheat LJ, Slama TG, Norton JA et al. Risk factors for disseminated or fatal histoplasmosis: Analysis of a large urban outbreak. Annals Intern Med 1982;96:159-63.
3. Lemense GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med 1994;150:258-60.
4. Roy V, Hammerschmidt DE. Disseminated histoplasmosis following prolonged low-dose methotrexate therapy. Am J Hematol 2000;63:59-60.
5. Witty LA, Steiner F, Curfman M, Webb D, Wheat LJ. Disseminated histoplasmosis in patients receiving low-dose methotrexate therapy for psoriasis. Arch Dermatol 1992;128:91-3.
6. Arunkumar P, Crook T, Ballard J. Disseminated histoplasmosis presenting as pancytopenia in a methotrexate-treated patient. Am J Hematol 2004;77:86-7.
7. Kanik KS, Cash JM. Does methotrexate increase the risk of infection or malignancy? Rheum Dis Clin N Amer 1997;23:955-67.
8. Fojtasek MF, Kleiman MB, Connolly-Stringfield P, Blair R, Wheat LJ. Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children. Pediatr Infect Dis J 1994;13:801-5.
9. Wallis PJW, Ryatt KS, Constable TJ. PCP complicating low dose methotrexate treatment for psoriatic arthropathy. Annals Rheum Dis 1989;48:247-9.
10. Klein-Gitelman MS, Szer IS. Disseminated Nocardia brasiliensis infection: An unusual complication of immunosuppressive treatment for childhood dermatomyositis. J Rheum 1991;18:1243-6.